Ganzhou Hemay Pharmaceutical Co., Ltd
Clinical trials sponsored by Ganzhou Hemay Pharmaceutical Co., Ltd, explained in plain language.
-
New hope for advanced cancer patients: Hemay181 trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called Hemay181 in 24 adults with advanced solid tumors that have stopped responding to standard treatments or have no standard options. The main goal is to see if the drug can shrink tumors and to check for side effects. Participants will …
Phase: PHASE1 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
First step: testing drug safety in people with liver issues
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a potential psoriasis medication, called Hemay005, is processed by the body in people with different levels of liver function. It will enroll 24 adults, some with mild or moderate liver impairment and others with normal liver function…
Phase: PHASE1 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Apr 17, 2026 16:10 UTC